Digest Network Come funziona
Network
/
Società
Un
Non verificato

United Therapeutics Corporation

Di cosa scriviamo

BiotecnologiaCardiologiaFarmaceuticaMedicina - VarieSalute

75 comunicati stampa

Guarda tutti i comunicati
08/09/2026
Finanza
Biotecnologia
Farmaceutica
Salute
Cardiologia
United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement for Remainder of $2.0 Billion Authorization
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
02/09/2026
Industria
Cardiologia
Biotecnologia
Farmaceutica
Sanità
Salute
Igiene alimentare
Medicina - Varie
United Therapeutics Corporation Announces FDA Acceptance of Supplemental New Drug Application for Nebulized Tyvaso® to Treat Idiopathic Pulmonary Fibrosis
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
01/09/2026
Eventi
Web e Social Network
Biotecnologia
Farmaceutica
Salute
Cardiologia
United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
28/08/2026
Eventi
Biotecnologia
Sanità
Salute
Farmaceutica
Cardiologia
United Therapeutics Presents Data at The European Society of Cardiology Congress 2026 and The European Respiratory Society International Congress 2026
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
24/08/2026
Industria
Scienza
Cardiologia
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hypertension
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
17/08/2026
Industria
Cardiologia
Biotecnologia
Farmaceutica
Sanità
Salute
Igiene alimentare
Medicina - Varie
United Therapeutics Corporation Announces Full Enrollment of the TETON-PPF Study of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
05/08/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Cardiologia
United Therapeutics Corporation Reports Second Quarter 2026 Financial Results
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
29/07/2026
Industria
Igiene alimentare
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Published in The Lancet
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
23/07/2026
United Therapeutics Corporation Announces Appointment of Victor Dzau to its Board of Directors
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
22/07/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Salute
Attrezzature medico-sanitarie
Sanità
Farmaceutica
Cardiologia
Biotecnologia
United Therapeutics Corporation to Report Second Quarter 2026 Financial Results Before Market Open on Wednesday, August 5, 2026
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0